Say the tool gives you a 5-year risk of one percent. This means the tool estimates one percent of women who have risk factors similar to yours will develop breast cancer over the next 5 years. So, if you use the tool on your own, it may be hard to understand the results and use the information to make decisions about your care. The Breast Cancer Risk Assessment Tool does not use all the known established risk factors for breast cancer to assess risk.
The tool also does not give a good risk estimate for some women, including those with a [ 1 ]:. Some tools, such as the Claus model, use family history to estimate breast cancer risk. Such tools can be used for women who have one or more relatives with breast cancer, or one or more relatives with ovarian cancer.
As research in risk assessment grows, tools like the Breast Cancer Risk Assessment Tool will be better able to predict risk in large groups of women. If you have questions about your breast cancer risk, talk with your doctor, nurse or other health care provider. Or create a new account it's free. Forgot Password? Sign In Required. To save favorites, you must log in. Creating an account is free, easy, and takes about 60 seconds. Log In Create Account. The principal investigators of the study request that you use the official version of the modified score here.
Gail Model for Breast Cancer Risk. Estimates risk for breast cancer based on demographic and clinical data. When to Use. Why Use. The Gail Model for Breast Cancer risk estimates the absolute 5 year risk and lifetime risk of developing breast cancer. Family history includes only first degree relatives with breast cancer, which is not enough information to estimate the risk of a patient having BRCA mutation.
It also underestimates the cancer risk for patients with extensive family history. The Gail Model is a good predictor of risk for populations but not for individuals. It may underestimate breast cancer risk in patients with atypical hyperplasia and strong family history.
Women who have received previous radiation therapy to the chest for treatment of Hodgkin lymphoma. First menstrual period. First live birth. No births. Edit Responses. Start A New Assessment.
Does the woman have a medical history of any breast cancer or of ductal carcinoma in situ DCIS or lobular carcinoma in situ LCIS or has she received previous radiation therapy to the chest for treatment of Hodgkin lymphoma?
Does the woman have a mutation in either the BRCA1 or BRCA2 gene, or a diagnosis of a genetic syndrome that may be associated with elevated risk of breast cancer? Has the patient ever had a breast biopsy with a benign not cancer diagnosis? How many breast biopsies with a benign diagnosis has the patient had? Has the patient ever had a breast biopsy with atypical hyperplasia?
0コメント